Kamada Ltd

KMDA71

$5.85arrow_drop_down0.17%-$0.01

KMDA71

$5.85

arrow_drop_down0.17%-$0.01

Performance History

Key Stats
Open	$6.03
Prev. Close	$6.03
EPS	0.27
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	5.83	6.12
52 Week Range	4.08	6.72

Ratios







EPS	0.27

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Kamada Ltd (KMDA)

Kamada Ltd (KMDA) is a biopharmaceutical company that specializes in the development, production, and marketing of plasma-derived protein therapeutics. With a strong focus on proprietary protein purification technology, Kamada is able to produce high-quality, safe, and effective biotherapeutics for various treatment options. The company's portfolio includes products for the treatment of various medical conditions, such as respiratory diseases, hemophilia, and immune deficiencies.

One of Kamada's key strengths is its extensive experience and expertise in the plasma-derived protein therapeutics field. The company has been in operation for over 25 years and has established itself as a leader in the industry. Kamada's manufacturing facilities comply with international quality standards and are equipped with advanced technology to ensure the production of top-tier products.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO
Headquarters: Rehovot
Employees: 380
Exchange: NASDAQ

Keep an eye on Kamada Ltd

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Kamada Ltd's (KMDA) price per share?

The current price per share for Kamada Ltd (KMDA) is $5.85. The stock has seen a price change of -$0.01 recently, indicating a -0.17% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Kamada Ltd (KMDA)?

For Kamada Ltd (KMDA), the 52-week high is $6.72, which is 14.96% from the current price. The 52-week low is $4.08, the current price is 43.38% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Kamada Ltd (KMDA) a growth stock?

Kamada Ltd (KMDA) has shown an average price growth of -4.94% over the past three years. It has received a score of 54 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Kamada Ltd as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Kamada Ltd (KMDA) stock price performance year to date (YTD)?

As of the latest data, Kamada Ltd (KMDA) has a year-to-date price change of -5.03%. Over the past month, the stock has experienced a price change of 11.01%. Over the last three months, the change has been 9.76%. Over the past six months, the figure is 3.36%. Looking at a longer horizon, the five-year price change stands at -1.85%.

help

Is Kamada Ltd (KMDA) a profitable company?

Kamada Ltd (KMDA) has a net income of $8.41M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 36.33% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 13.28% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $144.76M, with a revenue growth rate of 11.92%, providing insight into the company's sales performance and growth. The gross profit is $52.59M. Operating income is noted at $10.06M. Furthermore, the EBITDA is $30.05M.

help

What is the market capitalization of Kamada Ltd (KMDA)?

Kamada Ltd (KMDA) has a market capitalization of $336.9M. The average daily trading volume is 5.88, indicating the stock's liquidity and investor engagement.